Found: 30
Select item for more details and to access through your institution.
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1737-2
- By:
- Publication type:
- Article
A case of eosinophilic granulomatosis with polyangiitis as a mimicker of IgG4-related disease.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis.
- Published in:
- Hepatology Research, 2011, v. 41, n. 5, p. 492, doi. 10.1111/j.1872-034X.2011.00793.x
- By:
- Publication type:
- Article
The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
- Published in:
- International Journal of Rheumatic Diseases, 2020, v. 23, n. 4, p. 549, doi. 10.1111/1756-185X.13792
- By:
- Publication type:
- Article
Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 3, p. 434, doi. 10.1111/1756-185X.13387
- By:
- Publication type:
- Article
Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, p. 1, doi. 10.1186/s13075-015-0799-7
- By:
- Publication type:
- Article
Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0799-7
- By:
- Publication type:
- Article
Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2345, doi. 10.1093/rheumatology/kead568
- By:
- Publication type:
- Article
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
- Published in:
- Rheumatology, 2024, v. 63, n. 8, p. 2239, doi. 10.1093/rheumatology/kead579
- By:
- Publication type:
- Article
Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4875, doi. 10.1093/rheumatology/keac165
- By:
- Publication type:
- Article
Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus.
- Published in:
- Rheumatology, 2022, v. 61, n. 9, p. 3614, doi. 10.1093/rheumatology/keab953
- By:
- Publication type:
- Article
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study.
- Published in:
- Rheumatology, 2011, v. 50, n. 10, p. 1908, doi. 10.1093/rheumatology/ker221
- By:
- Publication type:
- Article
Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 10, p. 2029, doi. 10.1002/art.40180
- By:
- Publication type:
- Article
Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 6, p. 1077, doi. 10.1093/mr/roab113
- By:
- Publication type:
- Article
Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
- Published in:
- Modern Rheumatology, 2021, v. 31, n. 1, p. 94, doi. 10.1080/14397595.2020.1741870
- By:
- Publication type:
- Article
5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study.
- Published in:
- Modern Rheumatology, 2020, v. 30, n. 5, p. 799, doi. 10.1080/14397595.2019.1702141
- By:
- Publication type:
- Article
Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 6, p. 850, doi. 10.3109/14397595.2016.1153449
- By:
- Publication type:
- Article
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 3, p. 399, doi. 10.3109/14397595.2013.843757
- By:
- Publication type:
- Article
Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 3, p. 405, doi. 10.3109/14397595.2013.844294
- By:
- Publication type:
- Article
Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).
- Published in:
- Modern Rheumatology, 2011, v. 21, n. 2, p. 122, doi. 10.3109/s10165-010-0366-7
- By:
- Publication type:
- Article
Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.
- Published in:
- Modern Rheumatology, 2011, v. 21, n. 2, p. 184, doi. 10.3109/s10165-010-0370-y
- By:
- Publication type:
- Article
A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate.
- Published in:
- Modern Rheumatology, 2007, v. 17, n. 2, p. 144, doi. 10.3109/s10165-006-0548-5
- By:
- Publication type:
- Article
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1705, doi. 10.1007/s40744-023-00603-8
- By:
- Publication type:
- Article
Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02462-6
- By:
- Publication type:
- Article
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1933-8
- By:
- Publication type:
- Article
Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02934-3
- By:
- Publication type:
- Article
Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02845-3
- By:
- Publication type:
- Article
Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02547-2
- By:
- Publication type:
- Article